Statements (27)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:acquiredBy |
gptkb:Ginkgo_Bioworks
|
| gptkbp:acquisitionYear |
2022
|
| gptkbp:CEO |
gptkb:Joshua_Hoffman
|
| gptkbp:focusesOn |
materials science
synthetic biology bio-manufacturing |
| gptkbp:foundedIn |
2013
|
| gptkbp:founder |
gptkb:Jed_Dean
gptkb:Joshua_Hoffman gptkb:Zach_Serber |
| gptkbp:headquartersLocation |
gptkb:Emeryville,_California,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
Zymergen, Inc.
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:notableEvent |
IPO in April 2021
acquisition by Ginkgo Bioworks in 2022 leadership changes in 2021 stock price crash in 2021 |
| gptkbp:notableProduct |
gptkb:Hyaline
bio-based films |
| gptkbp:numberOfEmployees |
~350 (2021)
|
| gptkbp:publiclyTraded |
yes
|
| gptkbp:stockExchange |
gptkb:NASDAQ
|
| gptkbp:stockSymbol |
gptkb:ZY
|
| gptkbp:website |
https://www.zymergen.com/
|
| gptkbp:bfsParent |
gptkb:Sven_Strohband
|
| gptkbp:bfsLayer |
8
|